Latest Data Publication on Quantifying the Link Between TTR Response and Mortality Reduction
Daniel Judge, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
TTR Levels and Associated Disease Risk: Insights from 2025 PNS Conference
Ahmad Masri, MD, MS
Epilepsy: Beyond Seizure Impact
Raman Sankar, MD, PhD
Scott Aaronson, MD
Stemming the Tide on MASLD/MASH: It Starts on the Frontlines in Endocrinology and Primary Care Clinics
Meena B. Bansal, MD, FAASLD
Nicholas Pennings, DO, DABOM, MFOMA, FACOFP, FAAFP
Fernando Bril, MD
Optimizing Barostim Outcomes: Practical Approaches to Patient Selection and Monitoring
Cynthia J. Bither, ACNP-BC, MSN
Andrea Wallace, MSN, FNP-C, HF-Cert
Precision Medicine in IgAN: A Deep Dive Into Biomarkers, Evolving Guidelines, and Therapeutic Frontiers
September 19, 2025
Prague
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
Stefan D. Anker, MD, PhD
Mahir Karakas, MD, PhD, MBA
Impact of Barostim on Heart Failure Hospitalization
Jacob Abraham, MD
Tailoring Treatment for Optimal Outcomes in Patients With AAV
Bernhard Hellmich, MD
Andreas Kronbichler, MD
Elevating Care for Patients With Severe Renal Disease in AAV
Silke R. Brix, MD, MRCP, SCPR
Implementing the SOC Induction Therapies in AAV
Managing Patients With AAV in the Rheumatology Clinic
Beyond the Broadcast: Expert Insights on SGLT2 Inhibitors in Cardiometabolic Care
Melissa Magwire, RN, MSN, CDE
Matthew Bullington, PharmD
Dawn M. Denicola, FNP-C
Keith Miller, MD
No Patient Left Behind! Advancing CKD-Associated Pruritus Care
Kieran McCafferty, MD
Maurizio Gallieni, MD
Refining Strategies for Enhancing Cardiorenal Outcomes With SGLT2 Inhibitors: Optimizing the Cardiometabolic Care Model